A cohort of 2145 patients from the International Registry of Acute Aortic Dissection were compared according to whether they had axillary (1106 [52 percent]) or femoral (1039 [48 percent]) arterial cannulation.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Endovascular Techniques
July 11, 2024
September 12, 2023
Survivors of Acute Stanford B (DeBakey III) in Holland: a patient-cantered follow-up indicating that the treatment strategy did not influence quality of life.
July 11, 2022
There could be some translational value for cardiovascular surgical practice from this prospective cardiovascular health study. The mechanistic link warrants further investigation and interpretation.
May 20, 2022
This is a compreshensive review on the experience with use of TEVAR in patients with Marfan syndrome, including durablity, complications, and timing, etc. Drs. Steinmetz and Cosellihe also discussed the role and trend of TEVAR in Marfan paitents with aortic disease.
April 20, 2022
On April 20, 2020, Terumo Aortic announced that the US FDA has granted approval for the Thoraflex Hybrid frozen elephant trunk prothesis.
This is the first FET prosthesis commercially available in the US and will bring a new viable treatment option for patients with diseases of the aortic arch and descending aorta.
February 28, 2022
An interesting brief editorial on an experiment revisiting renal denervation as a panacea to cardiovascular disease
February 26, 2022
This newly released AHA scientific statement offers a comprehensive review of the latest imaging and measurement techniques for patients with chronic aortic dissection and clarifies the need for standardized measurements and reporting for lifelong surveillance.
February 18, 2022
The American Heart Association has released a scientific statement on imaging and surveillance of chronic aortic dissection, expounding the state-of-the-art imaging and measurement techniques (CT, MR and echocardiography), and clarifying the need for standardized measurements and reporting for lifelong surveillance.
July 12, 2021
In this article, Dr. Farber et al. describe the acceptable five year outcomes of using the Conformable GORE® TAG® thoracic endoprosthesis (CTAG) device (W.L. Gore and Associates, Flagstaff, AZ) for thoracic endovascular repair (TEVAR) of blunt aortic injuries in a prospective, single-arm study among 111 patients.
May 2, 2021
The AATS expert consensus document was recently released and focused on surgical treatment of acute type A aortic dissection.